Koen P van Rhee (K P van Rhee)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Pseudomonas Aeruginosa

Intensive Care Unit

Top Venues

Clinical pharmacokinetics

Journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Roger J M Brüggemann, Jason A Roberts, Fredrik Sjövall, Reinier M van Hest, Paul W G Elbers, Alan Abdulla, Paul D van der Linden, Catherijne A J Knibbe
Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity. Journal of clinical pharmacology 64 (9) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Roger J M Brüggemann, Jason A Roberts, Fredrik Sjövall, Reinier M van Hest, Paul W G Elbers, Alan Abdulla, Paul D van der Linden, Catherijne A J Knibbe
Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity. Journal of clinical pharmacology (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics (2024)
Koen P van Rhee, Cornelis Smit, Roeland E Wasmann, Paul D van der Linden, Marinus J Wiezer, Eric P A Van Dongen, Elke H J Krekels, Roger J M Brüggemann, Catherijne A J Knibbe
Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study. Clinical pharmacokinetics 61 (8) (2022)